Literature DB >> 22300613

Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention.

Harini S Aiyer1, Anni M Warri, Denzel R Woode, Leena Hilakivi-Clarke, Robert Clarke.   

Abstract

Breast cancer is the most commonly diagnosed cancer among women worldwide. Many women have become more aware of the benefits of increasing fruit consumption, as part of a healthy lifestyle, for the prevention of cancer. The mechanisms by which fruits, including berries, prevent breast cancer can be partially explained by exploring their interactions with pathways known to influence cell proliferation and evasion of cell-death. Two receptor pathways, estrogen receptor (ER) and tyrosine kinase receptors, especially the epidermal growth factor receptor (EGFR) family, are drivers of cell proliferation and play a significant role in the development of both primary and recurrent breast cancer. There is strong evidence to show that several phytochemicals present in berries such as cyanidin, delphinidin, quercetin, kaempferol, ellagic acid, resveratrol, and pterostilbene interact with and alter the effects of these pathways. Furthermore, they also induce cell death (apoptosis and autophagy) via their influence on kinase signaling. This review summarizes in vitro data regarding the interaction of berry polyphenols with the specific receptors and the mechanisms by which they induce cell death. This paper also presents in vivo data of primary breast cancer prevention by individual compounds and whole berries. Finally, a possible role for berries and berry compounds in the prevention of breast cancer and a perspective on the areas that require further research are presented.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300613      PMCID: PMC3383353          DOI: 10.1021/jf204084f

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  146 in total

1.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.

Authors:  J D Shull; T J Spady; M C Snyder; S L Johansson; K L Pennington
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

Review 2.  Role of autophagy in mammary gland development.

Authors:  M Gajewska; A Sobolewska; M Kozlowski; T Motyl
Journal:  J Physiol Pharmacol       Date:  2008-12       Impact factor: 3.011

3.  Radiolabelled cyanidin 3-O-glucoside is poorly absorbed in the mouse.

Authors:  Catherine Felgines; Stéphanie Krisa; Aurélie Mauray; Catherine Besson; Jean-Louis Lamaison; Augustin Scalbert; Jean-Michel Mérillon; Odile Texier
Journal:  Br J Nutr       Date:  2010-02-26       Impact factor: 3.718

Review 4.  Molecular and pharmacological aspects of antiestrogen resistance.

Authors:  R Clarke; T C Skaar; K B Bouker; N Davis; Y R Lee; J N Welch; F Leonessa
Journal:  J Steroid Biochem Mol Biol       Date:  2001 Jan-Mar       Impact factor: 4.292

5.  Lignans are accessible to human breast cancer xenografts in athymic mice.

Authors:  Niina M Saarinen; Krista A Power; Jianmin Chen; Lilian U Thompson
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

6.  Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats.

Authors:  M A Pereira; C J Grubbs; L H Barnes; H Li; G R Olson; I Eto; M Juliana; L M Whitaker; G J Kelloff; V E Steele; R A Lubet
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

7.  The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.

Authors:  Seiji Adachi; Tomokazu Nagao; Helgi I Ingolfsson; Frederick R Maxfield; Olaf S Andersen; Levy Kopelovich; I Bernard Weinstein
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

8.  Expression of sex steroid receptor subtypes in normal and malignant breast tissue - a pilot study in postmenopausal women.

Authors:  L Löfgren; L Sahlin; B Von Schoultz; R Fernstad; L Skoog; E Von Schoultz
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

Review 9.  Mammary gland growth factors: roles in normal development and in cancer.

Authors:  Nancy E Hynes; Christine J Watson
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-16       Impact factor: 10.005

10.  Co-inhibition of BCL-W and BCL2 restores antiestrogen sensitivity through BECN1 and promotes an autophagy-associated necrosis.

Authors:  Anatasha C Crawford; Rebecca B Riggins; Ayesha N Shajahan; Alan Zwart; Robert Clarke
Journal:  PLoS One       Date:  2010-01-06       Impact factor: 3.240

View more
  27 in total

1.  Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.

Authors:  Nisha R Parikh; Animesh Mandal; Deepak Bhatia; Kodappully Sivaraman Siveen; Gautam Sethi; Anupam Bishayee
Journal:  Phytochem Rev       Date:  2014-12       Impact factor: 5.374

Review 2.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

3.  Impact of apigenin and kaempferol on human head and neck squamous cell carcinoma.

Authors:  Hollie I Swanson; Eun-Young Choi; W Brian Helton; C Gary Gairola; Joseph Valentino
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-11-05

4.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Fatma Abdalla; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-09       Impact factor: 4.219

5.  Prevention of hormonal breast cancer by dietary jamun.

Authors:  Farrukh Aqil; Jeyaprakash Jeyabalan; Radha Munagala; Inder Pal Singh; Ramesh C Gupta
Journal:  Mol Nutr Food Res       Date:  2016-04-21       Impact factor: 5.914

6.  Suppression of inflammatory cascade is implicated in methyl amooranin-mediated inhibition of experimental mammary carcinogenesis.

Authors:  Animesh Mandal; Deepak Bhatia; Anupam Bishayee
Journal:  Mol Carcinog       Date:  2013-07-12       Impact factor: 4.784

Review 7.  Roles for miRNAs in endocrine resistance in breast cancer.

Authors:  Penn Muluhngwi; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2015-10       Impact factor: 5.678

8.  Resveratrol induces long-lasting IL-8 expression and peculiar EGFR activation/distribution in human keratinocytes: mechanisms and implications for skin administration.

Authors:  Saveria Pastore; Daniela Lulli; Riccardo Maurelli; Elena Dellambra; Chiara De Luca; Liudmila G Korkina
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

9.  Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines.

Authors:  Denzel R Woode; Harini S Aiyer; Nicole Sie; Alan L Zwart; Liya Li; Navindra P Seeram; Robert Clarke
Journal:  Int J Breast Cancer       Date:  2012-12-31

10.  Rhus coriaria induces senescence and autophagic cell death in breast cancer cells through a mechanism involving p38 and ERK1/2 activation.

Authors:  Hussain El Hasasna; Khawlah Athamneh; Halima Al Samri; Noushad Karuvantevida; Yusra Al Dhaheri; Soleiman Hisaindee; Gaber Ramadan; Nedaa Al Tamimi; Synan AbuQamar; Ali Eid; Rabah Iratni
Journal:  Sci Rep       Date:  2015-08-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.